News Sentiment

BALPHARMA sentiment intelligence

Bal Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 20 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 86.83 Week of 19 Jun 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+0.7% over one week, +5.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Compare with BAL PHARMA

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 0.7% Price digesting
Trend fit Trend active 5.9% over four weeks
Fair value -11.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 13
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MarketsMojo 6
Equitymaster 3
scanx.trade 3
simplywall.st 3
Moneycontrol.com 1
Trade Brains 1
Upstox 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 12
Earnings 4
Guidance 2
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20
Equitymaster Direct company coverage

Compare with BAL PHARMA

Tone
Neutral 50/100
Event
Market update
Published
20 Jun 2026 22:02
Source
Equitymaster